Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-2-18
pubmed:abstractText
Human immunodeficiency virus (HIV)-1-infected long-term nonprogressors (LT-NP) represent less than 5% of HIV-1-infected patients. In this work, we tried to understand whether combined genotypes of CCR5-triangle up32, CCR2-64I, SDF1-3'A and HLA alleles can predict the LT-NP status. Among the chemokine receptor genotypes, only the frequency of the CCR5-triangle up32 allele was significantly higher in LT-NP compared with the group of standard progressors. The predominant HLA alleles in LT-NP were HLA-A3, HLA-B14, HLA-B17, HLA-B27, HLA-DR6, and HLA-DR7. A combination of both HLA and chemokine receptor genotypes integrated in a multivariate logistic regression model showed that if a subject is heterozygous for CCR5-triangle up32 and homozygous for SDF1 wild type, his odds of being LT-NP are increased by 16-fold, by 47-fold when a HLA-B27 allele is present with HLA-DR6 absent, and by 47-fold also if at least three of the following alleles are present: HLA-A3, HLA-B14, HLA-B17, HLA-DR7. This model allowed a correct classification of 70% of LT-NPs and 81% of progressors, suggesting that the host's genetic background plays an important role in the evolution of HIV-1. The chemokine receptor and chemokine genes along with the HLA genotype can serve as predictors of HIV-1 outcome for classification of HIV-1-infected subjects as LT-NPs or progressors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
93
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
936-41
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:9920843-Adolescent, pubmed-meshheading:9920843-Adult, pubmed-meshheading:9920843-Alleles, pubmed-meshheading:9920843-Chemokine CXCL12, pubmed-meshheading:9920843-Chemokines, CXC, pubmed-meshheading:9920843-Cohort Studies, pubmed-meshheading:9920843-Disease Progression, pubmed-meshheading:9920843-Disease-Free Survival, pubmed-meshheading:9920843-Female, pubmed-meshheading:9920843-France, pubmed-meshheading:9920843-Genetic Predisposition to Disease, pubmed-meshheading:9920843-Genotype, pubmed-meshheading:9920843-HIV Infections, pubmed-meshheading:9920843-HIV Long-Term Survivors, pubmed-meshheading:9920843-HIV-1, pubmed-meshheading:9920843-HLA Antigens, pubmed-meshheading:9920843-Humans, pubmed-meshheading:9920843-Male, pubmed-meshheading:9920843-Middle Aged, pubmed-meshheading:9920843-Prognosis, pubmed-meshheading:9920843-Receptors, CCR2, pubmed-meshheading:9920843-Receptors, CCR5, pubmed-meshheading:9920843-Receptors, Chemokine, pubmed-meshheading:9920843-Receptors, Cytokine, pubmed-meshheading:9920843-Sequence Deletion
pubmed:year
1999
pubmed:articleTitle
Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals.
pubmed:affiliation
Laboratoire d'Immunologie Cellulaire et Tissulaire, UMR CNRS 7627, Hôpital Pitié-Salpêtrière, Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't